News

Latest news

Hide mandatory notifications of trade

Mandatory Notification of Trade

(Oslo, Norway, 14 October 2014) Bionor Pharma ASA Deputy Chairman Øystein Soug’s directly owned company Abakus Invest AS has on 13 October bought 79 545 shares in Bionor Pharma from Øystein Soug at NOK 2,38.Abakus Invest AS holds 107,205 shares after the transaction.

Mr. Soug and Abakus Invest AS’ total holdings are unchanged by the transaction. This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Securities Trading Act).